Developing novel and revolutionary therapies to promote gastro-intestinal health for patients with GI disorders
Avexegen Therapeutics Receives a $2.94M NIH Grant to
Advance Treatment for Inflammatory Bowel Disease
© 2015 | Avexegen Therapeutics, Inc.
10210 Campus Point Dr Ste 150
San Diego CA 92121
Avexegen Therapeutics, Inc.
10210 Campus Point Dr, Suite 150
San Diego, CA 92121